Medicare Enrolled

Dr. Mohamed Aboyoussef, M.D.

Rheumatology · Merritt Island, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
40 FORTENBERRY RD, Merritt Island, FL 32952
3214530779
In practice since 2006 (19 years)
NPI: 1972613057 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aboyoussef from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aboyoussef? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aboyoussef

Dr. Mohamed Aboyoussef is a rheumatology specialist in Merritt Island, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aboyoussef performed 440,472 Medicare services across 2,644 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aboyoussef received a total of $9,400 from 26 pharmaceutical and/or device companies across 412 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aboyoussef is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in FL $9,400 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 140157 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
440,472
Medicare services
Top 1% in FL for rheumatology
2,644
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~23,183 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
262,000 $4 $11
Tocilizumab injection (Actemra) 81,560 $5 $7
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
33,100 $34 $74
Romosozumab injection (Evenity) for osteoporosis 28,360 $8 $12
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
13,930 $11 $24
Denosumab injection (Prolia/Xgeva) 11,340 $18 $27
Rituximab injection, 10 mg
Administration of a 10 mg dose of rituximab medication via injection.
2,370 $63 $119
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
2,070 $26 $75
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
1,706 $55 $189
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,109 $94 $270
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
800 $98 $345
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
395 $10 $64
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
361 $1 $5
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
277 $121 $415
Injection, methylprednisolone acetate, 40 mg 174 $6 $30
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
154 $21 $110
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
148 $48 $177
Methylprednisolone injection, up to 40 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg.
114 $3 $20
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
107 $12 $85
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
99 $63 $184
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
94 $9 $40
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
55 $1 $2
Methylprednisolone acetate injection, 20 mg
A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered.
45 $4 $20
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
44 $36 $155
Tendon injection at attachment site
A procedure involving the injection of medication into a tendon where it attaches to bone or muscle.
22 $41 $183
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
19 $35 $156
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
19 $40 $145
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.3% high complexity
88.3% medium
0.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,400
Total received (2020-2024)
Avg $1,880/year across 5 years
Top 45% in FL for rheumatology
26
Companies
412
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,592 (70.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,462 (15.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,040 (11.1%)
Scientific / Research
Research funding and grants
$306 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,723
2023
$1,591
2022
$1,556
2021
$1,633
2020
$2,897

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,210
Amgen Inc.
$1,327
Horizon Therapeutics plc
$1,219
PFIZER INC.
$705
UCB, Inc.
$610
Novartis Pharmaceuticals Corporation
$565
AbbVie Inc.
$454
ABBVIE INC.
$443
Lilly USA, LLC
$393
Radius Health, Inc.
$311
Aurinia Pharma U.S., Inc.
$210
GlaxoSmithKline, LLC.
$166
SOBI, INC
$109
E.R. Squibb & Sons, L.L.C.
$109
GENZYME CORPORATION
$86
AstraZeneca Pharmaceuticals LP
$80
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
Genentech USA, Inc.
$68
Sobi, Inc
$52
Alexion Pharmaceuticals, Inc.
$50
Organon Llc
$45
Mallinckrodt Hospital Products Inc.
$37
Teva Pharmaceuticals USA, Inc.
$24
Mylan Institutional Inc.
$23
TerSera Therapeutics LLC
$17
Bioventus LLC
$14
Top 3 companies account for 50.6% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EVENITY · Enbrel · GELSYN-3 · HADLIMA · HUMIRA · Hulio · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · OFEV · ORENCIA · Otezla · PENNSAID · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Truxima · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a rheumatology specialist in Merritt Island?
Compare rheumatologists in the Merritt Island area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
9
Per 100K population
1.5
County median income
$75,817
Nearest hospital
CAPE CANAVERAL HOSPITAL
2.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Aboyoussef is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Aboyoussef experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Aboyoussef performed 262,000 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aboyoussef receive payments from pharmaceutical companies?
Yes. Dr. Aboyoussef received a total of $9,400 from 26 companies across 412 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aboyoussef's costs compare to other rheumatologists in Merritt Island?
Dr. Aboyoussef's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aboyoussef) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →